Evidence map›Paper›PMID 40091393›Full record

ArticleScience progress

The synthesis and characterization of Various metal complexes of 2-(4-nitrophenyl)-1H-benzimidazole and its mono schiff base precursor.

Zoltán Köntös, Máté Bartek

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zoltán KöntösIOI Investment Zrt., Budapest, Hungary.ORCID 0000-0001-9097-6741
Máté BartekDepartment of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Műegyetem rkp. 3, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis and application of metal complexes of 2-(4-nitrophenyl)-1H-benzimidazole, a significant heterocyclic compound, are rooted in the formation of its mono Schiff base precursor, N-(4-nitrobenzyl) benzene-1,2-diamine. This precursor is synthesized via the condensation of o-phenylenediamine (OPD) with 4-nitrobenzaldehyde (NBA). The formation of the Schiff base involves the nucleophilic attack of OPD's amino groups on the carbonyl carbon of 4-nitrobenzaldehyde, resulting in an imine linkage essential for subsequent cyclization reactions. Cyclization of the mono Schiff base N-(4-nitrobenzyl) benzene-1,2-diamine (NBD) is a crucial step in forming the benzimidazole ring. This compound's significance lies in its structural and electronic properties, influenced by the electron-withdrawing nitro group, making it valuable in coordination chemistry, medicinal chemistry, and materials science. In coordination chemistry, metal complexes of 2-(4-nitrophenyl)-1H-benzimidazole (NBI) acts as a ligand, forming stable complexes with transition metals that exhibit enhanced catalytic activity. These metal complexes are essential for various catalytic processes, including organic transformations and polymerization reactions. In medicinal chemistry, the benzimidazole core is a common motif in biologically active compounds. The presence of the nitro group can modulate the biological activity, making derivatives of 2-(4-nitrophenyl)-1H-benzimidazole (NBI) promising candidates for antimicrobial, anticancer, and antiviral agents. Research has also highlighted the applications of Schiff bases and their metal complexes in various fields. Schiff bases serve as versatile intermediates in the synthesis of heterocyclic compounds, while their metal complexes are explored for their catalytic, antimicrobial, and anticancer properties. The synthesis of 2-(4-nitrophenyl)-1H-benzimidazole and its derivatives remains a topic of significant interest due to their potential in developing new materials and pharmaceuticals. The synthesis of metal complexes of 2-(4-nitrophenyl)-1H-benzimidazole from its Schiff base precursor is a critical process with wide-ranging applications in coordination chemistry, medicinal chemistry, and materials science. The optimization of reaction conditions and the exploration of the compound's properties continue to drive research in this area, highlighting its importance in both fundamental and applied sciences.

Indexed as

benzimidazolebenzimidazole-derivatesmetal complexeso-phenylene-diamine

Identifiers

PMID40091393
PMCPMC11912178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.